UK researchers tested the tomato pill that contains lycopene, a natural antioxidant that also gives tomatoes their colour, versus a dummy drug in 72 adults and found it improved the functioning of blood vessels.
A spin-off company from the University of Cambridge - Cambridge Theranostics (CTL) - has come up with its own "tomato pill".
Working independently of CTL, a team at Cambridge University set out to see if the pill would have the desired effect.
To ensure a fairer trial, neither the volunteers nor the researchers were told what the tablets actually contained until after the two-month study had ended and the results were in, 'BBC News' reported.
For comparison, the researchers measured something called forearm blood flow, which is predictive of future cardiovascular risk because narrowed blood vessels can lead to heart attack and stroke.
In the heart disease patients, the tomato pill improved forearm blood flow significantly, while the placebo did not.
Lead researcher Dr Joseph Cheriyan said the findings were promising, but added: "A daily 'tomato pill' is not a substitute for other treatments, but may provide added benefits when taken alongside other medication.
"However, we cannot answer if this may reduce heart disease - this would need much larger trials to investigate outcomes more carefully," Cheriyan said.
The study was published in PLoS One journal.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
